Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo

Immunology

Volumn 129, Issue 1, 2010, Pages 20-27

  Ramelli, Giancarlo ^a   Fuertes, Silvia ^b   Narayan, Sharmal ^a   Busso, Nathalie ^a   Acha Orbea, Hans ^b   So, Alexander ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

AP2; Dendritic cells (DCs); Protease activated receptor 2 (PAR2); T cells

Indexed keywords

CD86 ANTIGEN; CELL ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; GLYCOPROTEIN P 15095; HERMES ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PADGEM PROTEIN; PROTEINASE ACTIVATED RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPH NODE; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN SENSITIZATION; SPLEEN; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; CELL DIFFERENTIATION; CELL MOVEMENT; DENDRITIC CELLS; FLUORESCEIN-5-ISOTHIOCYANATE; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 71649085949     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03144.x     Document Type: Article

References (46)

1. Busso N, Frasnelli M, Feifel R, Cenni B, Steinhoff M, Hamilton J, So A. Evaluation of protease-activated receptor 2 in murine models of arthritis. Arthritis Rheum 2007 56: 101 107.
2. Ferrell WR, Lockhart JC, Kelso EB et al. Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 2003 111: 35 41.
3. Hansen KK, Sherman PM, Cellars L et al. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc Natl Acad Sci USA 2005 102: 8363 8368.
4. Kawagoe J, Takizawa T, Matsumoto J et al. Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear. Jpn J Pharmacol 2002 88: 77 84.
5. Nakano S, Mishiro T, Takahara S et al. Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis. Clin Rheumatol 2007 26: 1284 1292.
6. Napoli C, de Nigris F, Wallace JL, Hollenberg MD, Tajana G, De Rosa G, Sica V, Cirino G. Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions. J Clin Pathol 2004 57: 513 516.
7. Noorbakhsh F, Tsutsui S, Vergnolle N et al. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 2006 203: 425 435.
8. Seeliger S, Derian CK, Vergnolle N et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 2003 17: 1871 1885.
9. Su X, Camerer E, Hamilton JR, Coughlin SR, Matthay MA. Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol 2005 175: 2598 2605.
10. Takizawa T, Tamiya M, Hara T, Matsumoto J, Saito N, Kanke T, Kawagoe J, Hattori Y. Abrogation of bronchial eosinophilic inflammation and attenuated eotaxin content in protease-activated receptor 2-deficient mice. J Pharmacol Sci 2005 98: 99 102.
11. D'Andrea MR, Derian CK, Leturcq D et al. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 1998 46: 157 164.
12. Damiano BP, Cheung WM, Santulli RJ et al. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J Pharmacol Exp Ther 1999 288: 671 678.
13. Cocks TM, Fong B, Chow JM et al. A protective role for protease-activated receptors in the airways. Nature 1999 398: 156 160.
14. Santulli RJ, Derian CK, Darrow AL, Tomko KA, Eckardt AJ, Seiberg M, Scarborough RM, Andrade-Gordon P. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci USA 1995 92: 9151 9155.
15. Kong W, McConalogue K, Khitin LM, Hollenberg MD, Payan DG, Bohm SK, Bunnett NW. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci USA 1997 94: 8884 8889.
16. Lindner JR, Kahn ML, Coughlin SR et al. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 2000 165: 6504 6510.
17. Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 2001 22: 146 152.
18. Lerner DJ, Chen M, Tram T, Coughlin SR. Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function. J Biol Chem 1996 271: 13943 13947.
19. Bohm SK, Kong W, Bromme D et al. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 1996 314 (Pt 3 1009 1016. (Pubitemid 26097768)
20. Molino M, Woolkalis MJ, Reavey-Cantwell J, Pratico D, Andrade-Gordon P, Barnathan ES, Brass LF. Endothelial cell thrombin receptors and PAR-2. Two protease-activated receptors located in a single cellular environment. J Biol Chem 1997 272: 11133 11141.
21. Kanke T, Macfarlane SR, Seatter MJ, Davenport E, Paul A, McKenzie RC, Plevin R. Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes. J Biol Chem 2001 276: 31657 31666.
22. Belham CM, Tate RJ, Scott PH, Pemberton AD, Miller HR, Wadsworth RM, Gould GW, Plevin R. Trypsin stimulates proteinase-activated receptor-2-dependent and-independent activation of mitogen-activated protein kinases. Biochem J 1996 320 (Pt 3 939 946.
23. Kelso EB, Lockhart JC, Hembrough T et al. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J Pharmacol Exp Ther 2006 316: 1017 1024.
24. Molino M, Barnathan ES, Numerof R et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997 272: 4043 4049.
25. Camerer E, Huang W, Coughlin SR. Tissue factor-and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 2000 97: 5255 5260.
26. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 2005 25: 1545 1550.
27. Coughlin SR, Camerer E. Participation in inflammation. J Clin Invest 2003 111: 25 7.
28. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004 84: 579 621.
29. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 1994 91: 9208 9212.
30. Nystedt S, Emilsson K, Larsson AK, Strombeck B, Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 1995 232: 84 9.
31. Hollenberg MD, Saifeddine M, al-Ani B. Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides. Mol Pharmacol 1996 49: 229 233.
32. Kanke T, Takizawa T, Kabeya M, Kawabata A. Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2 as a potential therapeutic target. J Pharmacol Sci 2005 97: 38 42.
33. McGuire JJ, Saifeddine M, Triggle CR, Sun K, Hollenberg MD. 2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist. J Pharmacol Exp Ther 2004 309: 1124 1131.
34. Csernok E, Ai M, Gross WL et al. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006 107: 4440 4448.
35. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003 3: 867 878.
36. Nagai Y, Garrett KP, Ohta S, Bahrun U, Kouro T, Akira S, Takatsu K, Kincade PW. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006 24: 801 812.
37. Rallabhandi P, Nhu QM, Toshchakov VY, Piao W, Medvedev AE, Hollenberg MD, Fasano A, Vogel SN. Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. J Biol Chem 2008 283: 24314 24325.
38. Kawabata A, Kanke T, Yonezawa D et al. Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo. J Pharmacol Exp Ther 2004 309: 1098 1107.
39. Thomas WR, Edwards AJ, Watkins MC, Asherson GL. Distribution of immunogenic cells after painting with the contact sensitizers fluorescein isothiocyanate and oxazolone. Different sensitizers form immunogenic complexes with different cell populations. Immunology 1980 39: 21 7.
40. Macatonia SE, Edwards AJ, Knight SC. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology 1986 59: 509 514.
41. Ebeling C, Lam T, Gordon JR, Hollenberg MD, Vliagoftis H. Proteinase-activated receptor-2 promotes allergic sensitization to an inhaled antigen through a TNF-mediated pathway. J Immunol 2007 179: 2910 2917.
42. Ebeling C, Forsythe P, Ng J, Gordon JR, Hollenberg M, Vliagoftis H. Proteinase-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways. J Allergy Clin Immunol 2005 115: 623 630.
43. Marsland BJ, Battig P, Bauer M et al. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 2005 22: 493 505.
44. Yoneyama H, Matsuno K, Zhang Y et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 2004 16: 915 928.
45. Fiorucci S, Mencarelli A, Palazzetti B et al. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci USA 2001 98: 13936 13941.
46. Fields RC, Schoenecker JG, Hart JP, Hoffman MR, Pizzo SV, Lawson JH. Protease-activated receptor-2 signaling triggers dendritic cell development. Am J Pathol 2003 162: 1817 1822.